Vergoeding 2017-2021 voor ATC-subgroep B03XA : Overige middelen bij anemie
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| B03XA01 Epoetine (Neorecormon ®) | 8.109.500 | 7.400.700 | 7.771.700 | 7.398.800 | 6.824.700 |
| B03XA02 Darbepoetine alfa (Aranesp ®) | 24.154.600 | 26.005.200 | 28.509.400 | 29.549.500 | 26.654.000 |
| B03XA03 Methoxypolyethyleenglycolepoetine beta (Mircera ®) | 2.306.700 | 2.301.000 | 2.448.800 | 2.515.500 | 2.469.100 |
| B03XA05 Roxadustat (Evrenzo ®) | . | . | . | . | 4.287 |
| Totaal | 34.570.800 | 35.706.900 | 38.729.900 | 39.463.800 | 35.952.087 |